Board of Directors

Associate, Goldman Sachs.
Former White House fellow, serving as special assistant to the Secretary of the Treasury
Previous employment included positions with Lazard Frères & Co., LLC, and McKinsey & Company Board member, USI Holdings Corp.

Founder and former Chief Clinical Officer of XLHealth.
Established system of evaluation and treatment leading to a significant reduction of complications causing lower extremity amputations.
Pioneered diabetic foot center concept; founder of Diabetic Foot Centers of America, Inc. where he developed the core of its diabetic lower extremity complication treatment protocols.
Nationally recognized for limb salvage and the conservative management of foot problems associated with diabetes.
Graduate of Illinois College of Podiatric Medicine in Chicago in 1972.
Completed residency in podiatric medicine and foot surgery at Monsignor Clement Kern Hospital for Special Surgery in Warren, Michigan.
Fellow of the American College of Foot Surgeons and a Diplomat of the American Board of Podiatric Surgery.

Co-founder, Vice President and General Counsel to Intralytix, Inc., a Baltimore-based, early-stage biotech company.
Former partner in the international law firm of McGuireWoods.
Former chairman, Maryland State Bar Association’s Business Law Section.
Former chairman, Maryland Bar Association’s Section on International Commercial Transactions.
Member, board of directors of MdBio, Inc., a non-profit organization dedicated to the development of the biotechnology industry in Maryland.
Previously served on the boards of two public companies: C3, Inc., a systems integration company and Tempest Technologies, Inc., a provider of specialized computer equipment and technology to security agencies.